|
Brief Reports
Citations 1-10 of 1228 total displayed.
|
Most recent content
(19 Nov 2009):
|
Platelet protein disulfide isomerase is localized in the dense tubular system and does not become surface expressed after activation
- Hezder E. van Nispen tot Pannerden, Suzanne M. van Dijk, Vivian Du, and Harry F. G. Heijnen
Blood 2009; 114: 4738-4740.
[Abstract]
[Full text]
[PDF]
Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura
- Hendrik B. Feys, Inge Pareyn, Renee Vancraenenbroeck, Marc De Maeyer, Hans Deckmyn, Chris Van Geet, and Karen Vanhoorelbeke
Blood 2009; 114: 4749-4752.
[Abstract]
[Full text]
[PDF]
|
Past content
(since Jul 1999):
|
The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients
- Bruno Paiva, Maria-Belén Vidriales, Gema Mateo, Jose J. Pérez, Maria Angeles Montalbán, Anna Sureda, Laura Montejano, Norma C. Gutiérrez, Alfonso García de Coca, Natalia de las Heras, Maria Victoria Mateos, Maria Consuelo López-Berges, Raimundo García-Boyero, Josefina Galende, Jose Hernández, Luis Palomera, Dolores Carrera, Rafael Martínez, Javier de la Rubia, Alejandro Martín, Yolanda González, Joan Bladé, Juan José Lahuerta, Alberto Orfao, Jesús F. San-Miguel, and on behalf of the GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Groups
Blood 2009; 114: 4369-4372.
[Abstract]
[Full text]
[PDF]
Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities
- Anja Mottok, Christoph Renné, Marc Seifert, Elsie Oppermann, Wolf Bechstein, Martin-Leo Hansmann, Ralf Küppers, and Andreas Bräuninger
Blood 2009; 114: 4503-4506.
[Abstract]
[Full text]
[PDF]
Recombinant canine B-domain–deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A model
- Denise E. Sabatino, Christian Furlan Freguia, Raffaella Toso, Andrey Santos, Elizabeth P. Merricks, Haig H. Kazazian, Jr, Timothy C. Nichols, Rodney M. Camire, and Valder R. Arruda
Blood 2009; 114: 4562-4565.
[Abstract]
[Full text]
[PDF]
Spatial gradients of blood vessels and hematopoietic stem and progenitor cells within the marrow cavities of the human skeleton
- Vincent A. Bourke, Christopher J. Watchman, John D. Reith, Marda L. Jorgensen, Arnaud Dieudonnè, and Wesley E. Bolch
Blood 2009; 114: 4077-4080.
[Abstract]
[Full text]
[PDF]
Wild-type FOXP3 is selectively active in CD4+CD25hi regulatory T cells of healthy female carriers of different FOXP3 mutations
- Sara Di Nunzio, Massimiliano Cecconi, Laura Passerini, Alicia N. McMurchy, Udo Baron, Ivana Turbachova, Silvia Vignola, Erica Valencic, Alberto Tommasini, Anne Junker, Giantonio Cazzola, Sven Olek, Megan K. Levings, Lucia Perroni, Maria Grazia Roncarolo, and Rosa Bacchetta
Blood 2009; 114: 4138-4141.
[Abstract]
[Full text]
[PDF]
Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies
- Christopher A. Tormey and Gary Stack
Blood 2009; 114: 4279-4282.
[Abstract]
[Full text]
[PDF]
Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies
- Animesh Pardanani, Ken-Hong Lim, Terra L. Lasho, Christy Finke, Rebecca F. McClure, Chin-Yang Li, and Ayalew Tefferi
Blood 2009; 114: 3769-3772.
[Abstract]
[Full text]
[PDF]
Amelioration of Sardinian β0 thalassemia by genetic modifiers
- Renzo Galanello, Serena Sanna, Lucia Perseu, Maria Carla Sollaino, Stefania Satta, Maria Eliana Lai, Susanna Barella, Manuela Uda, Gianluca Usala, Goncalo R. Abecasis, and Antonio Cao
Blood 2009; 114: 3935-3937.
[Abstract]
[Full text]
[PDF]
|
|
